Setting the criteria for totipotent stem cells


Stem cell research is the prerequisite for regenerative medicine, which with the help of the body’s cells recreates and heals important organs. Totipotent stem cells are cells that have the capacity to self-renew by dividing and to develop into the three primary germ cell layers of the early embryo and into extra-embryonic tissues such as the placenta. Indeed, totipotency such ability of a cell to generate every cell type in the early embryo as well as the embryo’s supporting structures, including the placenta. This ability is typically only found during the first few cell divisions of an embryo. There is a lot of interest in pushing the boundaries of stem cell potential in order to capture the totipotent state so we needed criteria to assess whether a stem cell line has actually achieved this goal. Replicating mouse stem cells in a totipotent state within a laboratory has been a long-sought goal of stem cell biologists around the world. If successfully created, such a stem cell line could have profound impact on the field, enabling the study of normal development and regenerative medicine. To date, mouse stem cell lines in a pluripotent state have been made. However, these cells can only make other cell types in the embryo or the placenta, but not both.

A team of researchers from Karolinska Institutet in Sweden, The Hospital for Sick Children in Canada and the KU Leuven in Belgium has provided a set of criteria to assess whether a mouse stem cell line shows true totipotency. The authors determined three criteria for a mouse stem cell line to be totipotent: the cells’ genetic activity, or gene expression profiles, need to be closer to that of an earlier embryo rather than pluripotent stem cells, the cells should be able to readily transform into placental stem cells or into an early embryo-like structure in an artificial environment and  most importantly, the cells should be able to contribute to the placenta as well as the fetus when returned into the environment of an early embryo. They developed a new method for defining the most general type of stem cells, that can develop into all cell types in the body. The research study of totipotent stem cells in mice has been published in Nature Cell Biology.

The team tested two different mouse stem cell lines that had been reported as potentially totipotent and assessed them using their criteria. While both lines showed some gene expression differences from pluripotent stem cells, they didn’t look like totipotent early embryo cells and didn’t make certain functional cells in the placenta.   The research has resulted in a clear set of criteria to validate any new cell lines. In addition, the team also developed a comprehensive analysis of gene expression and regulation at the single cell level for embryos and different pluripotent stem cell lines. The researchers believe this will be a valuable resource for the scientific community.

Setting the criteria for totipotent stem cells - Medicine Innovates
Figure legend: Mouse embryo following injection of truly totipotent morula cells labeled in magenta. Morula cells are found shortly after an egg is fertilized. Credit: Eszter Posfai

About the author

Janet Rossant PhD, FRS, FRSC

Dr. Janet Rossant, a world-renowned expert in developmental biology, is the definition of a trailblazer. She started as the Gairdner Foundation’s President and Scientific Director on May 4, 2016.

Widely known for her studies of the genes that control embryonic development in the mouse, Rossant has pioneered techniques for following cell fate and altering genes in embryos. This work continues to resonate in medical genetic research. Her current research focuses on stem cell development and cell differentiation in the developing embryo, important areas for the study of birth defects as well as regenerative medicine.

Dr. Rossant trained at the Universities of Oxford and Cambridge, United Kingdom and has been in Canada since 1977, first at Brock University and then at the Samuel Lunenfeld Research Institute within Mount Sinai Hospital in Toronto, from 1985 to 2005. She served as Chief of Research at SickKids from 2005 to 2015 and retains a research lab there. Dr. Rossant has been recognized for her contributions to science with many awards, including the Ross G. Harrison Medal (lifetime achievement award) from the International Society of Developmental Biologists, the Killam Prize for Health Sciences, the March of Dimes Prize in Developmental Biology, the Conklin Medal from the Society for Developmental Biology, the 10th ISTT Prize from the International Society for Transgenic Technologies and the 2018 L’Oréal For Women in Science Award. She is a Fellow of the Royal Societies of both London and Canada, and an International member of the US National Academy of Sciences.


Eszter Posfai, John Paul Schell, Adrian Janiszewski, Isidora Rovic, Alexander Murray, Brian Bradshaw, Tatsuya Yamakawa, Tine Pardon, Mouna El Bakkali, Irene Talon, Natalie De Geest, Pankaj Kumar, San Kit To, Sophie Petropoulos, Andrea Jurisicova, Vincent Pasque, Fredrik Lanner & Janet Rossant. Evaluating totipotency using criteria of increasing stringency. Nature Cell Biology (2021). DOI: 10.1038/s41556-020-00609-2

Go To Nature Cell Biology

About Priti